New York-based AI startup EliseAI is in talks for a new funding round that could value the company at about $3.7 billion. The deal could bring $300 million in new capital, according to a report from Business Insider. Andreessen Horowitz and Bessemer Venture Partners are in talks to lead the deal, although the final terms are not yet set.
If the deal closes at the reported value, it would mark a major rise for EliseAI. The company had a valuation of about $2.2 billion after its 2025 funding round. The new target would put its value about $1.5 billion higher than that earlier figure.
The possible deal also shows how much interest investors have in AI tools that solve real business problems. EliseAI does not focus on a general chatbot. Its software serves the housing and healthcare sectors, where companies deal with large volumes of calls, messages, appointments and other routine tasks.
What EliseAI Does
EliseAI was founded in 2017 and has its headquarters in New York. The company builds AI assistants for housing operators and healthcare firms.
In the housing sector, its software can help with apartment tour requests, appointment schedules and maintenance communication. It can also help property teams deal with questions from renters and residents.
The idea is simple. Property firms receive many requests each day, and staff must answer them, set up visits and deal with maintenance issues. EliseAI uses AI to handle many of these tasks.
The company has also expanded into healthcare. There, its tools can help with tasks such as invoicing and patient appointment schedules.
This focus on specific industries is a key part of EliseAI’s strategy. Rather than create one general AI product for everyone, the company builds tools for sectors with their own rules, needs and work processes.
From Housing to Healthcare
EliseAI first built its business around housing. It later expanded into healthcare, which gave the company a second large market.
The move makes sense because both sectors have a high volume of routine communication. A renter may need a response about a repair or a property visit. A patient may need help with an appointment or a bill.
These tasks may look simple, but they take a lot of staff time when a company has thousands or millions of customers.
EliseAI aims to use AI to reduce that workload. Its tools can handle communication through text, email and phone calls, according to Andreessen Horowitz. The company says its platform can also help with leasing, maintenance, billing and renewals.
This gives EliseAI a wider role than a simple chatbot. Its software can become part of the daily work of a housing or healthcare company.
A Major Funding History
The reported $300 million deal would come after a series of large funding rounds.
In 2024, EliseAI raised $75 million in a Series D round. That deal gave the company a valuation of more than $1 billion and made it a unicorn, a term for a private startup worth at least $1 billion.
A year later, the company raised $250 million in Series E funding. Andreessen Horowitz led that round, while Bessemer Venture Partners, Sapphire Ventures and Navitas Capital also took part.
That 2025 deal valued EliseAI at more than $2.2 billion. At the time, the company had also passed $100 million in annual recurring revenue, or ARR.
The reported 2026 deal would therefore be another large step in a short period.
Why Investors Like EliseAI
The possible $3.7 billion valuation comes from a wider rise in interest in vertical AI.
Vertical AI means software built for one specific industry or type of work. These tools can have an advantage over general AI because they can fit into a company’s existing processes.
Housing and healthcare are good examples. Both areas have complex systems and many tasks that follow set rules.
A general AI model may know how to answer a question, but a specialised system can connect that answer to a real business process. It can help schedule a visit, send a message, manage a request or support a staff member.
That makes EliseAI’s model attractive to businesses that want AI to do useful work rather than simply produce text.
EliseAI Has Already Reached $200M ARR
EliseAI’s business has grown quickly.
In June 2026, the company said it had passed $200 million in annual recurring revenue. It also said it had achieved 100% year-over-year growth for five straight years.
ARR is a useful measure for a software company because it shows the value of its recurring subscription revenue over a year.
The $200 million figure is twice the $100 million ARR that EliseAI reported in 2025. That pace of growth helps explain why investors may be ready to give the company a much higher valuation.
The company also says its software now supports 1 in 6 apartments in the US and that more than 2 million patients use EliseAI. Its website lists $400 million or more in total funding and $200 million in ARR.
Andreessen Horowitz Has Strong Confidence
Andreessen Horowitz, also known as a16z, has already shown strong confidence in EliseAI.
The firm led EliseAI’s $250 million Series E round in 2025. At that time, a16z said EliseAI had already become a major AI platform for the housing sector.
The firm also noted that EliseAI had reached more than 10% of the US apartment market at that point and had passed $100 million in ARR.
A new deal led by a16z and Bessemer would therefore represent another major vote of confidence.
Both firms are well known in the venture capital world. Their possible role in the new round shows that large investors continue to see strong value in AI firms with clear commercial use cases.
What the $300M Could Help EliseAI Do
The new capital could help EliseAI expand its products and enter more markets.
The company has already moved from housing into healthcare. More money could help it build new tools for both sectors and support more customers.
It could also help EliseAI improve its AI systems. The company works with complex business processes, so its software needs to deal with many different situations.
More capital could also support international growth.
EliseAI has already built a large base in the US. Its next stage could involve a wider global reach, although the company has not announced specific plans tied to the reported $300 million deal.
The Deal Is Not Final Yet
It is important to note that the reported $300 million round and $3.7 billion valuation are not final.
Business Insider reported that EliseAI is in the process of raising the new capital and that Andreessen Horowitz and Bessemer Venture Partners are in talks about the deal. The final amount, valuation and investor list could change before the round closes.
That means the $3.7 billion figure should be treated as a reported target rather than a completed valuation.
Still, even the talks are notable. A move from more than $2.2 billion in 2025 to a possible $3.7 billion in 2026 would show how quickly investors have raised their view of the company’s value.
A Bigger Test for Vertical AI
EliseAI’s possible new funding round is part of a larger story in the AI market.
Early AI investment often focused on general models and consumer tools. Now, investors are also looking at companies that use AI inside specific industries.
EliseAI is a strong example of this shift. Its software does not try to serve every possible customer. It focuses on two major areas, housing and healthcare, and aims to solve daily problems within those sectors.
That approach can create strong customer ties if the software becomes part of core business work.
The challenge is also clear. EliseAI must keep its rapid growth while its products become more complex. It must show that AI can create real value for customers and not just attract attention from investors.
EliseAI’s Next Chapter
A $300 million funding round at a $3.7 billion valuation, if completed, would mark another major stage in EliseAI’s growth.
The company has already moved from a $1 billion valuation in 2024 to more than $2.2 billion in 2025. It has also reached $200 million in ARR and continues to expand its AI tools across housing and healthcare.
The reported deal shows that investors still see strong potential in AI software that can handle real business tasks.
For EliseAI, the next goal will be to prove that its growth can continue at a large scale. If the company closes the new round at the reported terms, it will have more capital and a much higher value as it works to make AI a core part of housing and healthcare operations.
For the wider startup market, the story offers a simple lesson: AI value is no longer limited to general-purpose models. Companies that use AI to solve clear problems in major industries can also attract very large investments.
Also Read – Wispr Raises $280M at $2B Valuation in Voice AI Push